Phase II trial combining Oxaliplatin, Capecitabine, and Celecoxib with concurrent radiation for newly diagnosed resectable rectal cancer: COX-2 expression in relationship to outomces

2016

Poster presented at the 17th World Congress on Gastrointestinal Cancer, July 1 - July 14, 2015.

Keywords:

References

Citations